Literature DB >> 7679049

Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer.

A W Partin1, R H Getzenberg, M J CarMichael, D Vindivich, J Yoo, J I Epstein, D S Coffey.   

Abstract

The nuclear matrix represents the structural component of the nucleus that determines nuclear shape and higher order DNA organization. We have previously shown tissue specificity in nuclear matrix proteins (NMP), in rat sex accessory tissues, and in a rat model of prostate cancer. This study compares NMP patterns for fresh human normal prostate, benign prostatic hyperplasia (BPH), and prostate cancer for 21 men undergoing surgery for clinically localized prostate cancer or BPH. NMP patterns were compared using high resolution two-dimensional polyacrylamide gel electrophoresis. We identified by molecular weight and isoelectric point 14 different proteins that were consistently present or absent among the various tissues. One protein (PC-1), a M(r) 56,000 protein with an isoelectric point of 6.58, appeared in 14 of 14 different nuclear matrix preparations from prostate cancer and was not detected in normal prostate (0 of 13) or BPH (0 of 14). The NMP patterns are consistent with a model of disease progression in which BPH shares many of the nuclear matrix changes observed in prostate cancer.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7679049

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  Modulation of chromatin by MARs and MAR binding oncogenic transcription factor SMAR1.

Authors:  Kiran K Nakka; Samit Chattopadhyay
Journal:  Mol Cell Biochem       Date:  2009-10-03       Impact factor: 3.396

Review 2.  The Tpr protein: linking structure and function in the nuclear interior?

Authors:  M R Paddy
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

Review 3.  Nuclear matrix, dynamic histone acetylation and transcriptionally active chromatin.

Authors:  J R Davie
Journal:  Mol Biol Rep       Date:  1997-08       Impact factor: 2.316

4.  Association of serum EPCA-2 level with prostate cancer in Chinese Han population.

Authors:  Lei Wang; Ling Ma; Xinli Wang; Bing Li; Shan Guo; Qingdong Qiao
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

5.  Two minds create a third: an exploration of the universe, cancer, and symmetry with Donald S. Coffey.

Authors:  J James Frost
Journal:  Am J Clin Exp Urol       Date:  2018-04-01

Review 6.  Rethinking cell structure.

Authors:  S Penman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

Review 7.  Spinal cord compression in prostate cancer.

Authors:  J L Osborn; R H Getzenberg; D L Trump
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

Review 8.  Nuclear structure as a source of cancer specific biomarkers.

Authors:  Eddy S Leman; Robert H Getzenberg
Journal:  J Cell Biochem       Date:  2008-08-15       Impact factor: 4.429

9.  Clinical utility of prostate carcinoma molecular diagnostic tests.

Authors:  Scott B Shappell
Journal:  Rev Urol       Date:  2008

Review 10.  Urinary markers in screening patients with hematuria.

Authors:  Edmund Chiong; Kris E Gaston; H Barton Grossman
Journal:  World J Urol       Date:  2007-12-04       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.